| 1 |
Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib
Nusayba Ali Bagegni, Shana N. Thomas, Ning Liu et al. · Breast Cancer Research
Open access |
21 Nov 2017 |
74 |
| 2 |
Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy
Martina Bonechi, Francesca Galardi, Chiara Biagioni et al. · Oncotarget
Open access |
26 Mar 2018 |
55 |
| 3 |
A Companion Diagnostic With Significant Clinical Impact in Treatment of Breast and Gastric Cancer
Jan Trøst Jørgensen, Henrik Winther, Jon Askaa et al. · Frontiers in Oncology
Open access |
23 Jul 2021 |
44 |
| 4 |
Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)
Amelia McCartney, Chiara Biagioni, Gaia Schiavon et al. · European Journal of Cancer
|
3 May 2019 |
42 |
| 5 |
Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial
Judith Bjöhle, Jenny Bergqvist, J. Simon Gronowitz et al. · Breast Cancer Research and Treatment
|
Jun 2013 |
40 |
| 6 |
Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer
Anna-Maria Larsson, Pär‐Ola Bendahl, Kristina E. Aaltonen et al. · Scientific Reports
Open access |
11 Mar 2020 |
37 |
| 7 |
Plasma thymidine kinase 1 activity and outcome of ER+ HER2− metastatic breast cancer patients treated with palbociclib and endocrine therapy
Luc Cabel, Dan Rosenblum, Florence Lerebours et al. · Breast Cancer Research
Open access |
14 Sep 2020 |
30 |
| 8 |
Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant
Luca Malorni et al. · European Journal of Cancer
Open access |
13 Feb 2022 |
26 |
| 9 |
Significance of amino acid substitutions in the thymidine kinase gene of herpes simplex virus type 1 for resistance
Andreas Sauerbrei, Kristin Liermann, Kathrin Bohn et al. · Antiviral Research
|
10 Aug 2012 |
24 |
| 10 |
A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis
Jairam Krishnamurthy, Jingqin Rosy Luo, Rama Suresh et al. · npj Breast Cancer
Open access |
21 Mar 2022 |
23 |
| 11 |
Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial
Costanza Paoletti, William Eric Barlow, Erin Frances Cobain et al. · Clinical Cancer Research
Open access |
14 Sep 2021 |
20 |
| 12 |
Reverse transcriptase activity for quantitation of HIV-1 subtype C in plasma: Relation to RNA copy number and CD4 T-cell count
Elizabeth Seyoum, Dawit Wolday, Mulu Girma et al. · Journal of Medical Virology
|
2005 |
19 |
| 13 |
Screening of herpes simplex virus type 1 isolates for acyclovir resistance using DiviTum® assay
Andreas Sauerbrei, Susanne Vödisch, Kathrin Bohn et al. · Journal of Virological Methods
|
12 Dec 2012 |
17 |
| 14 |
Evaluation of serum thymidine kinase 1 activity as a biomarker for treatment effectiveness and prediction of relapse in dogs with non-Hodgkin lymphoma
Pierre Boyé, Franck Floch, François J. Serres et al. · Journal of Veterinary Internal Medicine
Open access |
26 May 2019 |
14 |
| 15 |
Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)
Mattias Bergqvist, Adrian Nordmark, Amy Williams et al. · Biomarkers
Open access |
17 Jan 2023 |
13 |
| 16 |
Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer
Alexios Matikas et al. · ESMO Open
Open access |
11 Mar 2021 |
13 |
| 17 |
Development of Phenotypic HIV-1 Drug Resistance After Exposure to Single-Dose Nevirapine
Adriaan Erasmus Basson, Matshediso Ntsala, Neil Alexander Martinson et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes
|
21 Nov 2008 |
11 |
| 18 |
Plasma Thymidine Kinase Activity as a Novel Biomarker in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibitors
Fernanda Costa Svedman, Marie Jalsenius, Veronica Höiom et al. · Cancers
Open access |
29 Jan 2022 |
8 |
| 19 |
The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial
Yajing Zhu, Ioannis Zerdes, Alexios Matikas et al. · Breast Cancer Research and Treatment
Open access |
4 Jan 2024 |
7 |
| 20 |
Dynamics of plasma thymidine kinase activity in metastatic melanoma reflects immune checkpoint inhibitor efficacy
Fernanda Costa Svedman, Marie Jalsenius, Vitali Grozman et al. · Acta Oncologica
Open access |
2 Sep 2022 |
3 |
| 21 |
A Subset of Non-Small Cell Lung Cancer Patients Treated with Pemetrexed Show 18F-Fluorothymidine “Flare” on Positron Emission Tomography
Preetha Aravind, Sanjay Popat, Tara D. Barwick et al. · Cancers
Open access |
22 Jul 2023 |
2 |
| 22 |
Plasma thymidine kinase activity as a prognostic biomarker in pancreatic ductal adenocarcinoma: a single-center prospective study
Ebba Asplund, Mattias Bergqvist, Maura Krook et al. · Scandinavian Journal of Gastroenterology
|
11 Apr 2023 |
2 |
| 23 |
Analysis of thymidine kinase serum levels by novel method DiviTum™ in multiple myeloma and monoclonal gammopathy of undetermined significance - comparison with imaging methods 99mTc-MIBI scintigraphy and 18F-FDG PET/CT
Jaroslav Bačovský, Miroslav Mysliveček, Jiří Minařík et al. · Biomedical Papers
Open access |
25 Feb 2014 |
2 |
| 24 |
Dynamic thymidine kinase activity independently captures treatment-specific biological response and is independently associated with outcomes in endocrine-resistant HR+ /HER2 − metastatic breast cancer: A translational analysis of the GEICAM/2013–02 PEARL trial
Ángel Guerrero-Zotano et al. · European Journal of Cancer
Open access |
25 May 2026 |
1 |
| 25 |
Prognostic role of thymidine kinase 1 activity in hormone receptor positive metastatic breast cancer. A systematic review and meta-analysis
Ilenia Migliaccio, Roberto Buonaiuto, Giulia Anichini et al. · The Breast
ReviewOpen access |
9 Sep 2026 |
0 |
| 26 |
518P Longitudinal evaluation of serum thymidine kinase 1 activity in patients with metastatic breast cancer (mBC) treated with trastuzumab deruxtecan (T-DXd)
R. Buonaiuto, A. Caltavituro, C. Biagioni et al. · ESMO Open
Open access |
May 2026 |
0 |
| 27 |
12P Circulating tumor DNA (ctDNA) and serum thymidine kinase activity (sTKa) in patients with endocrine resistant MBC treated with palbociclib and fulvestrant (P+F) in the PYTHIA trial
S. Tyekucheva, M. Benelli, T. Antoniolli Crestani et al. · ESMO Open
Open access |
May 2026 |
0 |
| 28 |
156eP Distinct sTK1 behavior in first line chemotherapy and endocrine therapy in the PASIPHAE phase II trial
A. Papakonstantinou, X Liu, M. Klintman et al. · ESMO Open
Open access |
May 2026 |
0 |
| 29 |
Combining circulating inflammatory proteins and thymidine kinase activity to predict survival in melanoma patients receiving immune checkpoint inhibitors
S. Egyhazi Brage, Fernanda Costa Svedman, Mattias Bergqvist et al. · Immuno-Oncology Technology
Open access |
19 Mar 2026 |
0 |
| 30 |
Serum thymidine kinase activity in older patients with HR-positive and HER2-negative advanced breast cancer treated with ribociclib and letrozole in the RibOB trial
Maxime Van Houdt, C. Kenis, Magnus H. J. Bergqvist et al. · Journal of Geriatric Oncology
|
Nov 2025 |
0 |
| 31 |
Thymidine kinase activity as a prognostic tool in blood samples of primary ovarian cancer patients.
Stefanos Ioannis Moukas, Sabine Kasimir‐Bauer, Fabinshy Thangarajah et al. · Journal of Clinical Oncology
Open access |
28 May 2025 |
0 |
| 32 |
Budget impact analysis of the DiviTum TKa assay in postmenopausal women with hormone receptor positive metastatic breast cancer
Josh John Carlson, Gregory F. Guzauskas, Robert A. Dann et al. · Journal of Medical Economics
Open access |
2021 |
0 |
| 33 |
25P A Novel Serum Thymidine Kinase Activity (S-TK) Assay for Quantification of Total Cell Division in Man, with Special Reference to Breast Carcinoma
Simon Gronowitz, B. Nisman, Tanir M. Allweis et al. · Annals of Oncology
Open access |
May 2012 |
0 |
| 34 |
Serum Thymidine Kinase Activity Compared with CA 15-3 in Locally Advanced and Metastatic Breast Cancer as Part of a Prospective and Randomized Study
Judith Bjöhle, Jenny Bergqvist, Simon Gronowitz et al. · Annals of Oncology
Open access |
22 Apr 2013 |
0 |